John Toomey Appointed Vice President of Growth and Innovation of RMS Medical Products

Northwell Health Ranked Nation’s Top Health System for Diversity

New York State’s largest health care provider and private employer made the list for the ninth straight year and remained in the top spot in the 2021 DiversityInc rankings for Hospitals and Health Systems.

ZAP Surgical and Swiss Neuro Radiosurgery Center Announce Imminent Installation of New Gyroscopic Radiosurgery Platform for Treating Brain Tumors

ZAP-X is also the first and only dedicated radiosurgery system to no longer require Cobalt-60 radioactive sources, thus eliminating the significant costs to license, secure and regularly replace live radioactive isotopes.

Kathy Sherwood Joins Pelvital USA, Inc. Board of Directors

Sherwood's experience, which includes a diverse group of medical product companies such as Boston Scientific, American Medical Systems, St. Jude Medical, Kinetic Concepts, Transoma Medical and Medtronic, gives her an understanding of the problems faced by both large and small companies.

John Toomey
John Toomey

John Toomey has been appointed to the newly created position of Vice President of Growth and Innovation of RMS Medical Products. John Toomey brings to RMS over 30 years of medical device industry experience as an executive, patent officer, inventor, board member, and advisor.

Mr. Toomey will be responsible for research and development, product innovation, and business development, and integrating these capabilities across the enterprise. He will also play a key role in building a robust IP platform.

Mr. Toomey has held leadership roles at numerous medical device companies, including Pneuma Systems Corporation, Validose, Inc., Halkey-Roberts Corporation, Smith’s Medical, Inc., and CR Bard (acquired by Becton Dickinson). He also founded 2ME Mgmt Consultancy, LLC, which specialized in developing latent market opportunities and solving project, regulatory and IP challenges in the medical device space.

Mr. Toomey received his BS from Allegheny College, MBA from the Marshall School of Business at the University of Southern California, and JD from Thomas Jefferson School of Law.

Mr. Toomey holds 24 U.S. and foreign patents.

“Product innovation is a key driver of our previously announced strategic plan to become the preferred drug delivery partner for specific infusion therapies in select markets,” said Don Pettigrew, President and CEO of RMS Medical. “John has an impressive track record of developing and commercializing value-creating medical device solutions, and we are confident in his ability to help RMS pioneer new infusion products and applications. John is the latest in a series of strategic hires and appointments that we believe have positioned RMS Medical for continued growth and an elevated industry profile.”

“I am excited to join the team at RMS Medical at this important stage of development,” said Mr. Toomey. “The Company has a well-respected family of infusion therapy products, is addressing growing end markets, and is led by a seasoned and accomplished group of executives. I look forward to working with the team and building upon RMS Medical’s patient-focused platform.”

 

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine here.

Related Articles